研究员赢得极具声望的$100,000奖金

annie66

在治疗慢性肝炎 B 的工作中取得突破性进展的爱德蒙顿研究员得到了$100,000的奖金. 博士 Lorne Tyrrell,前亚伯达大学医药学院长,在治疗肝炎方面享有极高的声誉。

他和他的研究队伍为找出治疗肝炎 B 病毒的方法花了数年去测试化合物,这种病毒将会侵入肝脏，引起肝炎，肝癌，肝硬化。当他开始这项研究时,只得到了很少的赞助。他不得不在爱德蒙顿西部的父母的农场里用鸭肝作测试。这项研究最终取得了圆满的成功，研究的抗癌新药在 1998就得到了美国和加拿大的使用推广许可。而且慢性肝炎 B的治疗方法得到了 120多个国家的认可。
, E* `$ b0 t" i! {* D/ p
在 这种口服药发明之前,唯一的方法是注射治疗, 不但贵而且有严重的副作用。
/ Q5 X( T7 m; c3 u9 Y
/ @. a# X+ U  B7 w& `世界卫生组织估计有超过 350,000,000的的人得了慢性肝炎 B 。

antelope

标题少了个0。最好加上reference，这样规范一点，也是对原作者版权的尊重。

Zhujiaolian

Originally posted by antelope at 2005-9-21 22:56:
, d7 t, Z4 ?( l" ~$ f* U标题少了个0。最好加上reference，这样规范一点，也是对原作者版权的尊重。

9 I  P: \! c! e6 S4 v" c
# D: \" m: j5 G3 {$ u少了一个0，差别太大了。到底是一百万还是十万？如果只有10万，那还不如我们中国学人(UA毕业的生化博士)得到的25万多呢！

精品中年老男人

Originally posted by Zhujiaolian at 2005-9-22 08:35 AM:
# r6 T* H  _+ L/ |) e
8 l" l# F: L- `
5 i3 v' M) i% A2 K, Z. v少了一个0，差别太大了。到底是一百万还是十万？如果只有10万，那还不如我们中国学人(UA毕业的生化博士)得到的25万多呢！

- p* L' X1 E% A  D1 R
25w薪水?还是奖金??

annie66

原文如下
3 y0 C2 Y  H( m% a$ V
! g7 ~8 P- P9 O' R1 i+ LResearcher wins prestigious award
# O! D% K) _* P8 @5 n( @  
, [3 Y: u3 X0 C0 Z/ b: v
Edmonton Journal


+ J8 s1 V$ \; ^# \$ kWednesday, September 21, 2005
" G9 ~, O  q" T/ [' z) J
/ d3 ]3 V2 J% @3 q, ?# `
An Edmonton researcher whose work led to a breakthrough in treating chronic hepatitis B has received an award worth $100,000.

/ r/ w" b0 j; F$ GDr. Lorne Tyrrell, former dean of medicine at the University of Alberta, was honoured by the Ernest C. Manning Awards Foundation for his lifetime work in treating the disease.
/ C! }7 M6 Q4 Z2 p5 z
He and his research team spent years testing chemical compounds to find a way of stopping hepatitis B viruses, which infect the liver and can cause cirrhosis of the liver, liver cancer, liver failure and death.

He says when he started his research, funding was so tight that he tested chemical compounds on livers of ducks he raised on his parents’ farm west of Edmonton.
; Y- t  ~' c. o# d$ T, |. S
  n9 |# s/ ~$ a. L! C, z$ hThe research led to creation of the drug lamivudine, which was approved for use in the United States and Canada in 1998 and is now licensed in more than 120 countries for treatment of chronic hepatitis B infection.

- ]3 o) K: w/ ?' i4 {# `Before lamivudine, which is taken orally, the only treatment was taking injections of interferon, which is expensive and had serious side effects.

; a' W/ M2 C# t; IThe World Health Organization estimates that more than 350-million people around the world suffer from chronic hepatitis B.

annie66

可能是我的眼力不好，请大家对照原文，看看我丢的那个0在那里？
: C5 A: c3 B% @6 ]# t4 B$ H谢谢

antelope

原来标题少了个0，内容里的没问题。可能哪个超级版主帮你改回来了。

annie66

我这就去欣赏你的大作。
- k2 p/ Z4 j/ ^+ k; b% R5 }
1 x* P6 U7 a/ O  u7 p[ Last edited by annie66 on 2005-9-23 at 12:17 AM ]

propeller

Zhujiaolian

Originally posted by 又见清风 at 2005-9-22 07:54:
! Q% L9 ]- @: l! x+ K
0 L, n) P  k' [. o, e9 g1 T
4 n( @; y- m, j5 H! ^" M8 m; j  p6 b25w薪水?还是奖金??

6 Z& F* D5 y( z/ |7 I25W Research Achievement Award from Canadian federal government, not salary.